Neutral
Vanguard Group Inc. Sells 62,890 Shares of Halozyme Therapeutics, Inc. $HALO
Vanguard Group Inc. decreased its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 0.5% during the fourth quarter, according to ...